April 2013

Demand that Schwab Drop Forced Arbitration

Submitted by Chris Scholl on Tue, 04/23/2013 - 14:31

Public Citizen is running an important petition against Charles Schwab & Co., Inc. for its use of forced arbitration in contracts.  If you are a private investor doing business with Schwab, you should consider registering your complaint by signing this petition.   

CISPA Limits Incentives for Corporate Responsibly

Submitted by John Bowman on Mon, 04/22/2013 - 16:09

The U.S. House of Representatives passed the Cyber Intelligence Sharing and Protection Act (CISPA), H.R. 624, last week and the bill is set to be taken up by the Senate quickly.  

While there is across-the-board agreement on the need to update the nation’s cybersecurity laws, CISPA contains broad provisions that eliminate the ability of harmed individuals and business to hold corporations accountable that have acted recklessly or negligently after receiving cyber threat information. 

Legal Rights in Question with FDA Action on Metal Hips

Submitted by Jennifer Fuson on Fri, 04/19/2013 - 15:21

Taxpayers and patients could pay the price for faulty metal-on-metal hips when the U.S. Food and Drug Administration (FDA) reclassifies several metal-on-metal hips, requiring manufacturers to complete a premarket approval application (PMA) or product development protocol (PDP) in order to receive the agency’s approval.  The reclassification may put patients’ legal rights in question.

Take Action to Protect your Medicine Cabinet!

Submitted by Jennifer Fuson on Wed, 04/10/2013 - 17:23

Generic drugs make up 80% of all prescriptions filled in the United States, and roughly 53 billion dollars in sales.  Despite that, the U.S. Supreme Court recently held in Pliva v. Mensing that generic drug manufacturers have no responsibility to update their warning labels when they learn of new side-effects.  As a result, generic drug makers cannot be held accountable, even if their drug injures or even kills someone. The Supreme Court left it to Congress to change the law.  

Read the real story of Camille Baruch to learn how the access of justice has been denied for generic drug patients.  

Congress needs to amend the law to allow both generic and brand manufacturers to be responsible for their drugs’ safety.  Send a message to your member of Congress today!

What Justice for Victims of Oklahoma Dentist?

Submitted by Chris Scholl on Mon, 04/01/2013 - 17:52

As some 7,000 patients of a Tulsa dentist now face the real possibility that they have been exposed to HIV or hepatitis in his care, they also face harsh limits on their access to accountability and justice.